Interestingly, nucleolin is more abundantly expressed on the surface of tumor cell membranes than normal cells, which means that nucleolin can be a potential therapeutic target for anti-tumor (Koutsioumpa and Papadimitriou, 2014; Palmieri et al., 2015; Romano et al., 2018). The gene discussed is NUCLEOLIN; the disease is neoplasm.